• STT3A-Driven FCN3 N-Glycosylation Regulates Treg Activation

  2026-04-28

  This study reveals that STT3A-mediated N-glycosylation of FCN3 at Asn189 disrupts the tumor-suppressive function of FCN3, thereby promoting regulatory T cell (Treg) activation and hepatocellular carcinoma (HCC) progression via Wnt/β-catenin signaling. These findings highlight a new glycosylation-dependent immune evasion mechanism with potential therapeutic implications for HCC intervention.

• CP-673451 (SKU B2173): Reliable PDGFRα/β Inhibition in Cance

  2026-04-28

  This article addresses core laboratory challenges in cell viability, proliferation, and angiogenesis assays by demonstrating how CP-673451 (SKU B2173) delivers reproducible and selective PDGFRα/β inhibition. Integrating peer-reviewed data and real-world scenarios, we highlight the compound's unique workflow advantages for cancer researchers and lab technicians.

• Biofilm and Antibiotic Resistance Assays: HotStart™ Green qP

  2026-04-27

  Discover how HotStart™ Universal 2X FAST Green qPCR Master Mix empowers precise gene expression analysis in biofilm and antibiotic resistance research. This article uniquely integrates cutting-edge qPCR reagent technology with practical insights from Listeria monocytogenes biofilm studies.

• Moxidectin in Veterinary and Antifungal Science: Mechanisms

  2026-04-27

  Explore moxidectin as a macrocyclic lactone anthelmintic, revealing its dual impact on parasitic worm control and its novel synergy with polyene antifungals. This article provides deep mechanistic insight and practical assay guidance not covered elsewhere.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial I

  2026-04-26

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent with potent activity against Gram-positive and Gram-negative bacteria. It functions by inhibiting bacterial DNA gyrase and topoisomerase IV, with proven efficacy in both in vitro and in vivo respiratory tract infection models. Its application parameters and limitations are precisely defined for research use.

• Refining In Vitro Drug Response: Fractional vs. Relative Via

  2026-04-25

  Schwartz's dissertation pioneers a nuanced framework for evaluating anticancer drug responses by distinguishing between relative and fractional viability. This approach reveals how different drugs variably affect proliferation and cell death, enabling more precise preclinical assessment and informing translational strategies.

• Light-Inducible RNA-Releasing Proteins for Precision Gene Th

  2026-04-24

  A recent study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that functions as a gene switch, enabling precise, light-controlled translational regulation in mammalian cells. This innovation provides a platform for on-demand gene therapies, especially for chronic metabolic and retinal diseases, by leveraging optogenetic control mechanisms.

• 3-Aminobenzamide (PARP-IN-1): Precision PARP Inhibition in T

  2026-04-24

  3-Aminobenzamide (PARP-IN-1) stands out as a potent, workflow-friendly PARP inhibitor for dissecting oxidative stress, immune signaling, and diabetic nephropathy. This article delivers scenario-driven protocols, troubleshooting guidance, and actionable insights for maximizing assay reproducibility—translating cutting-edge bench research into robust experimental outcomes.

• Firefly Luciferase mRNA (5-moUTP): Optimizing Reporter Assay

  2026-04-23

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) redefines bioluminescent reporter assays with enhanced stability, immune evasion, and sustained expression. Explore optimized experimental workflows, practical troubleshooting, and the latest insights on innovative mRNA delivery strategies for reliable, high-sensitivity research applications.

• Z-WEHD-FMK: Precision Caspase Inhibition for Inflammation Re

  2026-04-23

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) delivers targeted, irreversible inhibition of inflammatory caspases for dissecting complex cell death and infection pathways. Its robust performance in apoptosis and infectious disease models empowers reproducible, high-impact research across cell biology and immunology.

• (S)-(+)-Dimethindene maleate: Practical Guide for M2 Antagon

  2026-04-22

  (S)-(+)-Dimethindene maleate is a selective tool for researchers investigating muscarinic M2 receptor signaling and histamine H1 antagonism in autonomic regulation, cardiovascular, and respiratory studies. Its well-defined solubility and receptor selectivity streamline assay setup and control, but it should not be used for diagnostic or medical applications.

• Protease Inhibitor Cocktail (100X): Enabling Precision in Pr

  2026-04-22

  Explore how the Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) empowers researchers with advanced protein degradation prevention and optimal assay integrity. Gain unique insights from recent oncology findings and technical protocol considerations.

• CCK-8 Promotes ANP Secretion via NOX4–PGC-1α–PPARα/γ Pathway

  2026-04-21

  This study elucidates the molecular cascade by which sulfated cholecystokinin octapeptide (CCK-8s) enhances atrial natriuretic peptide (ANP) secretion in isolated rat atria. By mapping the NOX4–PGC-1α–PPARα/γ signaling axis, the work provides key mechanistic insight into cardiac hormone regulation and redox signaling, with implications for cardiovascular and inflammation research.

• Tivozanib (AV-951): Optimizing VEGFR Inhibition in Oncology

  2026-04-21

  Tivozanib (AV-951) stands out for its unmatched selectivity and potency in VEGFR pathway inhibition, enabling robust, reproducible in vitro data. This guide delivers actionable protocol enhancements, troubleshooting strategies, and insight from recent reference studies to empower oncology workflows and maximize the translational potential of anti-angiogenic drug research.

• CCCP (carbonyl cyanide m-chlorophenyl hydrazine) in Mitochon

  2026-04-20

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is an indispensable tool for disrupting mitochondrial proton gradients, enabling advanced disease modeling and high-content biomarker discovery. This article bridges deep-learning–enabled mitochondrial morphology analysis with bench-proven CCCP workflows, providing actionable protocols, troubleshooting strategies, and a critical translation of recent AI-powered innovations.

451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page